Betahistine dihydrochloride, BETASERC 24 mg, comprimé
0796-19
Phase 3 small_molecule active
Quick answer
Betahistine dihydrochloride, BETASERC 24 mg, comprimé for Menière's disease is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Menière's disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active